A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

Fatty liver disease affects more than 1 in 3 adults and often has no symptoms. A new drug developed with Tulane researchers ...

The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic ...

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Nurse practitioners form the key to providing culturally competent care, which improves outcomes for Asian American patients.

The PALMARES-2 trial reveals that abemaciclib and ribociclib outperform palbociclib in real-world progression-free survival ...

As per the recent health updates, Shoaib shared that though Dipika has undergone a surgery, there is a high risk of cancer ...

Yiviva, a clinical-stage biotechnology company pioneering systems biology-driven therapeutics, announced data from its ...

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically ...

According to Dr Akshat Malik, Principal Consultant, Surgical Oncology, Cancer Care/ Head & Neck Oncology, Robotic Surgery, ...

Fatty liver is one of the conditions that are being rampantly reported, but the symptoms remain unknown to the patients. The ...